Patents
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
08/2006
08/15/2006US7091325 Fibrin/fibrinogen-binding conjugate
08/15/2006US7091324 For diagnosis and therapy of HCV infection, including being useful in the identification of patients expected to benefit from certain therapeutic strategies
08/15/2006US7091323 Human TIMP-1 antibodies
08/15/2006US7091322 Human endometrial specific steroid-binding factor I, II, and III
08/15/2006US7091321 Enhancing the circulating half-life of antibody-based fusion proteins
08/15/2006US7091047 Methods and kits for diagnosing tumorigenicity
08/15/2006US7091022 Mitogen activated kinase
08/15/2006US7091018 Enzyme gene and its expression product
08/15/2006US7091007 Comprises nucleotide sequences coding bone morphogenic and serine/threonine receptor proteins for for identifying modulators for use in prevention and treatment of bone and/or cartilage disorders
08/15/2006US7091006 Isolated nucleic acid of given sequence; use in identifying metabolic and neurological disorders
08/15/2006US7090986 identifying compounds such as antibodies that compete with the binding of Saratin to collagen by determining the binding of said Saratin to collagen in the presence or absence of a competitor.
08/15/2006US7090850 Proteins in enteroaggregative Escherichia coli (EAEC) useful for diagnosis and therapy of EAEC infections
08/15/2006US7090847 antibody/fragment binds interleukin or fusion protein; immunology; tissue-targeted therapy
08/15/2006US7090845 Diagnosis and treatment of hepatic disorders
08/15/2006US7090844 monoclonal antibody comprising a heavy chain amino acid; treatment of disorders associated with increased activity of MUC18, in particular, tumors, such as melanomas.
08/15/2006US7090843 immunotherapy; fusion proteins; antitumor agents; for treatment and prevention of hodgkin's disease
08/15/2006US7090842 antigen-binding fragment comprises immunoglobulin variable region light chains and heavy chains, produced by hybridoma; fusion proteins
08/10/2006WO2006084264A2 Cd20 antibody variants and uses thereof
08/10/2006WO2006084226A2 Antibodies that bind to epha2 and methods of use thereof
08/10/2006WO2006084129A2 Genes of porphyromonas gingivalis w83 involved in invasion of human cells
08/10/2006WO2006084092A2 Antibodies to oncostatin m receptor
08/10/2006WO2006084078A2 Jam-3 and antibodies that bind thereto
08/10/2006WO2006084075A2 Adam-9 modulators
08/10/2006WO2006084006A1 Human antibodies against rabies and uses thereof
08/10/2006WO2006083971A2 Dr5 antibodies and uses thereof
08/10/2006WO2006083964A2 Modified fusion molecules for treatment of allergic disease
08/10/2006WO2006083957A2 Tat-001 and methods of assessing and treating cancer
08/10/2006WO2006083936A2 Anti-ephb2 antibodies and methods using same
08/10/2006WO2006083852A2 Luca2 and antibodies that bind thereto
08/10/2006WO2006083792A2 Novel polypeptide ligands for toll-like receptor 2 (tlr2)
08/10/2006WO2006083562A2 Method and multicomponent conjugates for treating cancer
08/10/2006WO2006083289A2 Methods and compositions for enhancement of immunity by in vivo depletion of immunosuppressive cell activity
08/10/2006WO2006082851A1 Mucin relating to epiglycanin
08/10/2006WO2006082826A1 METHOD OF IDENTIFYING PURKINJE CELL TARGETING Corl2 GENE
08/10/2006WO2006082798A1 Monoclonal antibody specifically recognizing rat type i microglia
08/10/2006WO2006082406A2 Human antibodies and proteins
08/10/2006WO2006082066A1 Diagnosis of allergic complaints, atopic diseases and/or auto-immune diseases by the identification of antibodies against cd28 in human serum
08/10/2006WO2006059069A3 Ion channel
08/10/2006WO2006039644A3 Methods of treating cd30 positive lymphomas
08/10/2006WO2006033688A3 Anti-lympho- plus anti-monocytes globulin preparation for inhibiting immune responses
08/10/2006WO2006028634A3 Site specific pegylation of broadly-neutralizing antibodies against hepatitis c virus and their use in the treatment of chronic hcv infections
08/10/2006WO2006026097A3 Pegylation of antibodies against hiv
08/10/2006WO2006005585A3 Secreted polypeptide species differentially expressed during pregnancy
08/10/2006WO2005120166A3 Antibodies for selective apoptosis of cells
08/10/2006WO2005115455A3 Methods and reagents for the treatment of immunoinflammatory disorders
08/10/2006WO2005092073A3 Use of anti-alpha5beta1 antibodies to inhibit cancer cell proliferation
08/10/2006WO2005085280A3 HUMAN cDNA CLONES COMPRISING POLYNUCLEOTIDES ENCODING POLYPEPTIDES AND METHODS OF THEIR USE
08/10/2006WO2005083065A1 High glyphosate-tolerant epsp synthase from halomonas variabilis and its encoding sequence
08/10/2006WO2005069724A3 Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of cardiac disease
08/10/2006WO2003065999A3 Proliferated cell lines and uses thereof
08/10/2006US20060179496 Nucleic acid sequences differentially expressed in cancer tissue
08/10/2006US20060178504 Eotaxin: eosinophil chemotactic cytokine
08/10/2006US20060178503 Antibody to an integrin heterodimer and/or a subunit thereof
08/10/2006US20060177909 Preparation of immunoglobulin
08/10/2006US20060177904 Nucleotide sequences coding protein factors for use in identifying modulators for diagnosis, treatment and prevention of cell proliferative, metabolic, inflammatory, nervous system and immune disorders
08/10/2006US20060177903 Polynucleotide encoding a novel human G-protein coupled receptor variant of HM74, HGPRBMY74
08/10/2006US20060177901 Flt4 (VEGFR-3) as a target for tumor imaging and anti-tumor therapy
08/10/2006US20060177897 PR1550 polypeptides and nucleic acids encoding the same
08/10/2006US20060177896 Anti-CD3 antibodies and methods of use thereof
08/10/2006US20060177881 Antibodies against type A botulinum neurotoxin
08/10/2006US20060177876 Monoclonal antibody against asialo alpha 1-acid glycoprotein, immunochromatographic strip comprising the monoclonal antibody, and method for diagnosing liver diseases using the immunochromatographic strip
08/10/2006US20060177875 Tryptase polypeptide and uses thereof
08/10/2006US20060177866 Transmembrane serine protease overexpressed in ovarian carcinoma and uses thereof
08/10/2006US20060177862 Ribosome display
08/10/2006US20060177861 Novel compositions and methods in cancer associated with altered expression of MCM3AP
08/10/2006US20060177854 Hereditary hemochromatosis gene
08/10/2006US20060177831 c-MET kinase binding proteins
08/10/2006US20060177820 Relates to a kit for detecting and distinguishing one or more small round structure viruses (hereinafter called "SRSVs") in a specimen; SRSV detection kit comprising all antibodies against SRSV-related virus constituting peptides; human viral gastroenteritis
08/10/2006US20060177514 Preparation of a therapeutic composition
08/10/2006US20060177466 Novel proteins in enteroaggregative Escherichia coli (EAEC) useful for diagnosis and therapy of EAEC infections
08/10/2006US20060177457 Are designed to produce both Type 1 and Type 2 phototherapeutic effect at once using dual wavelength light source that will produce singlet oxygen and free radicals at the lesion of interest; for dual phototherapy of tumors and other lesions
08/10/2006US20060177456 Apo-2 receptor antibodies
08/10/2006US20060177455 Anti-CD33 antibodies and method for treatment of acute myeloid leukemia using the same
08/10/2006US20060177454 Method of promoting an immune response with a bispecific antibody
08/10/2006US20060177453 Effective in inhibiting tumor cell growth; immunotherapy; purified immunoglobulin; preventing or delaying development of metastasis, treating metastatic cancer, or inhibiting proliferation of metastatic cancer cells
08/10/2006US20060177452 EphB receptor-binding peptides
08/10/2006US20060177451 Binding molecules for the treatment of myeloid cell malignancies
08/10/2006US20060177450 isolated mammalian nucleic acid molecule; antibody; suppressing or modulating metastatic ability of prostate tumor cells, prostate tumor growth or elimination of prostate tumor cells; antitumor agents; gene expression inhbition
08/10/2006US20060177449 Antibody and use thereof
08/10/2006US20060177447 Anti-IL-20, anti-IL-22 and anti-IL-22RA antibodies and binding partners and methods of using in inflammation
08/10/2006US20060177446 Polypeptides that bind an anti-tissue factor antibody and uses thereof
08/10/2006US20060177444 Concomitant drug as therapeutic agent for inflammatory bowel disease
08/10/2006US20060177441 Agonist antibodies
08/10/2006US20060177440 Compositions and methods for detection of antibody binding to cells
08/10/2006US20060177439 FcgammaRIIB-specific antibodies and methods of use thereof
08/10/2006US20060177437 Binding peptides: methods for their generation and use
08/10/2006US20060177428 Expression vector comprising nucleotide sequences coding endothelial growth factor for use in diagnosis, prevention and treatment of tumor disorders
08/10/2006CA2597198A1 Antibodies that bind to epha2 and methods of use thereof
08/10/2006CA2597171A1 Antibodies to oncostatin m receptor
08/10/2006CA2596835A1 Antigen binding molecules that bind egfr, vectors encoding same, and uses thereof
08/10/2006CA2596833A1 Human antibodies and proteins
08/10/2006CA2596697A1 Human antibodies against rabies and uses thereof
08/10/2006CA2596514A1 Riproximin , a novel type ii ribosome-inactivating protein and uses thereof
08/10/2006CA2596273A1 Adam-9 modulators
08/10/2006CA2595906A1 Libraries and methods for isolating antibodies
08/10/2006CA2595792A1 Cd20 antibody variants and uses thereof
08/10/2006CA2594918A1 Dr5 antibodies and uses thereof
08/10/2006CA2594636A1 Anti-ephb2 antibodies and methods using same
08/09/2006EP1688496A2 Regulation of human P2Y1-like G protein-coupled receptor
08/09/2006EP1688495A1 MU-1 member of the cytokine receptor family